English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 中国の関節炎治療薬市場
カテゴリ
医薬品 (4955)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (182)
感染症 (351)
規制環境 (130)
後発医薬品 (134)
骨疾患 (37)
処方薬 (157)
神経疾患 (174)
精神疾患 (88)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

中国の関節炎治療薬市場

Chinese Markets for Arthritis Treatment Drugs

発行 Asia Market Information & Development
出版日 2009年06月 商品コード 91216
ページ情報 英文 201 Pages
価格
US$ 4,000 換算 ¥ 322,760 (税抜) PDF by E-mail (Single User License)
US$ 8,000 換算 ¥ 645,520 (税抜) PDF by E-mail (Corporate Use License)


原文目次

Abstract

China' s demand for Arthritis Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Table of Contents

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ARTHRITIS TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Arthritis Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Driver
  • Arthritis Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. ARTHRITIS TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
  • Arthritis Treatment Drugs Sales Volume
  • NSAIIDs
  • SAARDs
  • DMARDs
  • Immunosuppressant
  • Traditional Chinese Medicine
  • Biological agents
  • Antibiotics
  • Arthritis Treatment Drugs Imports and Exports
  • Arthritis Treatment Drugs Imports
  • SAARDs Import
  • DMARDs Import
  • Immunosuppressant Import
  • NSAIIDs Import
  • Traditional Chinese Medicine Import
  • Biological Agents Import
  • Antibiotics Import
  • Arthritis Treatment Drugs Exports
  • SAARDs Export
  • DMARDs Export
  • Immunosuppressant Export
  • NSAIIDs Export
  • Traditional Chinese Medicine Export
  • Biological Agents Export
  • Antibiotics Export
  • Pricing Trend

V. ARTHRITIS TREATMENT DRUGS MARKET OUTLOOK

  • Arthritis Treatment Drug Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China' s Distribution System
  • Arthritis Treatment Drug Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China' s Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. PRODUCER DIRECTORY

  • Arthritis Treatment Drug Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ARTHRITIS TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Arthritis Treatment Drugs Sales Volume (million us dollars)
  • Arthritis Treatment Drugs Sales Volume (percent)
  • Major Producer Facility Location
  • Major Arthritis Treatment Drug Producer Sales Volume
  • Major Foreign Investment in China

IV. ARTHRITIS TREATMENT DRUGS PRODUCTION AND DEMAND

  • Arthritis Treatment Drugs Sales Volume
  • NSAIIDs Major Producer and Their Market Share in 2008
  • SAARDs Major Producer and Their Market Share in 2008
  • Traditional Chinese Medicine Major Producer and Their Market Share in 2008
  • Biological Agents Major Producers and Their Market Share in 2008
  • Antibiotics Major Producer and Their Market Share in 2008
  • Arthritis Treatment Drugs Major Producer and Their Market Share in 2008
  • Arthritis Treatment Drugs Import
  • Arthritis Treatment Drugs Export

V. ARTHRITIS TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Arthritis Treatment Drug Sales Volume

II. BUSINESS ENVIRONMENT

  • China' s GDP and Growth Rate
  • Industrial Output by Ownership
  • China' s Imports and Exports

III. ARTHRITIS TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • SAARDs Drug Sales Volume by Drugs Classification in 2008
  • Arthritis Treatment Drug Sales Volume
  • Arthritis Treatment Drug Sales Volume by Drugs Classification in 2008

IV. ARTHRITIS TREATMENT DRUGS PRODUCTION AND DEMAND

  • Total Arthritis Treatment Drugs Sales Volume
  • NSAIIDs Sales Volume and Market Share
  • SAARDs Sales Volume and Market Share
  • DMARD Sales Volume and Market Share
  • Immunosuppressant Sales Volume and Market Share
  • Traditional Chinese Medicine Sales Volume and Market Share
  • Biological Agent Sales Volume and Market Share
  • Antibiotics Sales Volume and Market Share
  • Arthritis Treatment Drugs Import
  • SAARDs Import by Drugs Classification
  • Arthritis Treatment Drugs Export
  • SAARDs Import, Export and Net Import
  • DMARDs Import, Export and Net Import
  • Immunosuppressant Import, Export and Net Import
  • NSAIIDs Import, Export and Net Import
  • Traditional Chinese Medicine Import, Export and Net Import
  • Biological Agents Import, Export and Net Import
  • Antibiotics Import, Export and Net Import

VI. MARKETING STRATEGIES

  • China' s Distribution Channel
Back to Top